Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "JOURNAL OF CLINICAL ONCOLOGY"

Add to list
Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Wim Ceelen (UGent) , Louis Sandra (UGent) , Leen Van de Sande (UGent) , Martin Graversen, An Vermeulen (UGent) , Dries Reynders (UGent) , Sarah Cosyns (UGent) , Anne Hoorens (UGent) and Wouter Willaert (UGent)

(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(Supplement 15). p.4065-4065
Add to list
- Conference Paper
- C3
Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan Andreas Burger, Peter Hillmen, Steve E. Coutre, Stephen Devereux, Sebastian Grosicki, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(15).
Add to list
- Journal Article
- A1
- open access
Glofitamab, a novel, bivalent CD20-targeting T-cell-engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma : a phase I trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmelo Carlo-Stella, Fritz Offner (UGent) , Anna Sureda, Gilles Salles, Joaquin Martinez-Lopez, Michael Crump, Denise N. Thomas, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(18). p.1959-1971
Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Conference Paper
- C3
Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results

Peter Van Dam, Yannick Verhoeven, Jorrit De Waele, Julie Jacobs, Pieter-Jan Van Dam, Mark Kockx, Koen Van de Vijver (UGent) , Martin Lammens, An Wouters, Evelien Smits, et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(15).
Add to list
- Conference Paper
- C3
Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).

Ben Tran, Lisa Horvath, Matthew Rettig, Karim Fizazi, Martijn P. Lolkema, Tanya B. Dorff, Richard Greil, Jean-Pascal H. Machiels, Karen A. Autio, Sylvie Rottey (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(15).
Add to list
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M. Dunning, James Redman, James Scarth, Inga Plaskocinska, et al.

(2020) Journal of Clinical Oncology. 38(7). p.674-687
Add to list
- Journal Article
- A1
- open access
Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas Matthyssens (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(25). p.2902-2916
Add to list
- Journal Article
- A1
- open access
Has the PROPHECY of AR-V7 been fulfilled?

Bram De Laere, Piet Ost (UGent) , Henrik Gronberg and Johan Lindberg

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(24). p.2181-2182
Add to list
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial

Simone N. Koole, Christiaan van Lieshout, Willemien J. van Driel, Evi van Schagen, Karolina Sikorska, Jacobien M. Kieffer, Jules H. Schagen van Leeuwen, Henk W.R. Schreuder, Ralph H. Hermans, Ignace H. de Hingh, et al.

(2019) Journal of Clinical Oncology. 37(23). p.2041-2050

Academic Bibliography

Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Glofitamab, a novel, bivalent CD20-targeting T-cell-engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma : a phase I trial

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results

Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Has the PROPHECY of AR-V7 been fulfilled?

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial

Contents

Support

Contact